{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:38Z","timestamp":1791560978325,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Signet ring cells are extremely rare in primary endometrial carcinomas with a limited number of reported cases. We report a series of 5 endometrioid-type endometrial carcinomas with signet ring cells, the largest reported series in the literature to date. The patients ranged in age from 53 to 89\u00a0yr (mean: 72), and all presented with postmenopausal bleeding. Four of the tumors were FIGO grade 3, and 1 FIGO grade 2, and the FIGO stages were IA, IB, IIIA, IIIB, and IIIC1. The percentage of signet ring cells ranged from 10% to 30% of the tumor, and the signet ring cells were confined to solid areas of the neoplasm. All tumors were positive with estrogen receptor (ER) (4 diffuse, 1 focal); p53 immunohistochemistry was wild-type in 4 and diffuse mutation-type in 1. Three neoplasms were mismatch repair (MMR) deficient (loss of MLH1\/PMS2) on immunohistochemistry. Molecular testing revealed a\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    pathogenic variant with an associated ultramutated phenotype in one of the MMR-proficient tumors and a\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    mutation in the tumor exhibiting mutation-type p53 staining (this was also MMR proficient on immunohistochemistry). Using The Cancer Genome Atlas (TCGA) molecular classification, tumors were\n                    <jats:italic toggle=\"yes\">POLE<\/jats:italic>\n                    mutated (n=1), MMR deficient (n=3), and p53 abnormal (n=1). On follow-up, 4 patients were alive with no evidence of disease (4\u201324\u00a0mo follow-up), and 1 patient died 7\u00a0mo after diagnosis from an unrelated cause. In reporting these neoplasms, we highlight that signet ring cells occasionally occur in primary endometrial carcinomas of endometrioid-type and, although numbers are small, there appears to be an association with MMR deficiency. These tumors have a propensity for high-stage at presentation.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001183","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:01:15Z","timestamp":1778148075000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Endometrial Endometrioid Carcinomas With Signet Ring Cells: Report of a Case Series With Detailed Clinical, Pathologic, and Molecular Analysis"],"prefix":"10.1097","volume":"45","author":[{"given":"Megan","family":"Ryan","sequence":"first","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"McConnell","sequence":"additional","affiliation":[{"name":"Regional Molecular Diagnostics Service, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Catherwood","sequence":"additional","affiliation":[{"name":"Regional Molecular Diagnostics Service, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/PGP.0b013e3181e20c66","article-title":"Endometrial adenocarcinoma with signet ring cells: report of two cases of an extremely rare phenomenon","volume":"29","author":"Boyd","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004347-199704000-00014","article-title":"Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasis","volume":"16","author":"Mooney","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/PGP.0b013e3181c1cbf2","article-title":"Primary signet-ring cell adenocarcinoma of the endometrium: case report and review of the literature","volume":"29","author":"Chebib","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20261009","first-page":"380571","article-title":"HPV11 positive endometrioid carcinoma of the endometrium with signet-ring cells: diagnostic criteria and review of the literature","volume":"2014","author":"Pusiol","year":"2014","journal-title":"Case Rep Pathol"},{"key":"R5-20261009","first-page":"404692","article-title":"Primary endometrial adenocarcinoma with signet-ring cells: a rarely observed case and review of the literature","volume":"2015","author":"Akkalp","year":"2015","journal-title":"Case Rep Obstet Gynecol"},{"key":"R6-20261009","first-page":"180","article-title":"Case report primary endometrial endometrioid carcinoma with signet ring cells: an unexpected morphology of a common tumor","volume":"2","author":"Shahin","year":"2015","journal-title":"Am J Clin Exp Obstet Gynecol"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"879","DOI":"10.31083\/j.ejgo.2020.06.2185","article-title":"Primary endometrial carcinoma with signet-ring cells. A case report and review of the literature","volume":"41","author":"Sierra","year":"2020","journal-title":"Eur J Gynaecol Oncol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"300669","DOI":"10.1016\/j.hpr.2022.300669","article-title":"Endometrial adenocarcinoma with signet ring cell features\u2014a report of a rare case with literature review","volume":"29","author":"Ismail","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"101046","DOI":"10.1016\/j.gore.2022.101046","article-title":"Intestinal type adenocarcinoma of the endometrium with signet ring cells, a rare aggressive variant","volume":"42","author":"Seay","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"K\u00f6bel","year":"2016","journal-title":"J Pathol Clin Res"},{"issue":"Iss 1 Suppl 1","key":"R12-20261009","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38 Suppl 1","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/his.15365","article-title":"Initiation of molecular testing of endometrial carcinomas in a population-based setting: practical considerations and pitfalls","volume":"86","author":"Machuca-Aguado","year":"2025","journal-title":"Histopathology"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PAS.0000000000002382","article-title":"Primary endometrial gastric (gastrointestinal)-type mucinous adenocarcinoma: a detailed clinicopathologic and molecular analysis of 27 cases","volume":"49","author":"Kaur","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PGP.0000000000000843","article-title":"Postchemotherapy endometrioid to gastrointestinal histotype shift in recurrent endometrial carcinoma","volume":"41","author":"Arciuolo","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004347-200110000-00002","article-title":"Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells","volume":"20","author":"Che","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"e254190","DOI":"10.1136\/bcr-2022-254190","article-title":"Metastatic signet-ring carcinoma to the uterus presenting as an endometrial polyp","volume":"16","author":"Amin","year":"2023","journal-title":"BMJ Case Rep"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1447-0756.2011.01807.x","article-title":"Signet-ring cell carcinoma of the breast with uterine metastasis treated with extensive cytoreductive surgery: a case report and brief review of the literature","volume":"38","author":"Ertas","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/gyno.1998.5126","article-title":"Signet ring breast carcinoma metastases limited to the endometrium and cervix","volume":"71","author":"Kennebeck","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R20-20261009","first-page":"563","article-title":"Endometrial metastasis from signet-ring breast carcinoma: case report","volume":"23","author":"Chehal","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"2050313X20907208","DOI":"10.1177\/2050313X20907208","article-title":"Lobular breast carcinoma metastatic to the endometrium in a patient under tamoxifen therapy: a case report","volume":"8","author":"Gomez","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7819-10-7","article-title":"A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: immunohistochemical and molecular studies and review of the literature","volume":"10","author":"Giordano","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.5858\/2004-128-1032-NHHOTE","article-title":"Nodular histiocytic hyperplasia of the endometrium","volume":"128","author":"Fukunaga","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1309\/RL5H-VC5D-9WE2-X71H","article-title":"Nonneoplastic endometrial signet-ring cells: vacuolated decidual cells and stromal histiocytes mimicking adenocarcinoma","volume":"115","author":"Iezzoni","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/jcp.2007.054767","article-title":"Signet ring cells of stromal derivation in the uterine cervix secondary to cauterisation: report of a previously undescribed phenomenon","volume":"61","author":"McKenna","year":"2008","journal-title":"J Clin Pathol"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004347-198603000-00008","article-title":"Adenomatoid tumor of uterus: presentation in endometrial curettings","volume":"5","author":"Carlier","year":"1986","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/PAI.0000000000000614","article-title":"A case report of an adenomatoid tumor of the uterus mimicking an endometrioid adenocarcinoma on endometrial curetting: a diagnostic pitfall","volume":"28","author":"Mhawech-Fauceglia","year":"2020","journal-title":"App Immunohistochem Mol Morphol"},{"issue":"Suppl 1","key":"R28-20261009","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/PGP.0000000000000741","article-title":"Grading of endocervical adenocarcinomas: review of the literature and recommendations from the International Society of Gynecological Pathologists","volume":"40","author":"Talia","year":"2021","journal-title":"Int J Gynecol Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:12Z","timestamp":1791558072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001183","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"2026-03-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}